BiotechTube
Home/Pipeline/ABBV-647

ABBV-647

Prostate Cancer

Phase 1ActiveNCT04631601

Key Facts

Indication
Prostate Cancer
Phase
Phase 1
Status
Active
Company
AbbVie

About AbbVie

AbbVie's mission is to discover and deliver transformative medicines that solve serious health issues. Its landmark achievement was building the world's top-selling drug, Humira, into a franchise while successfully navigating its patent expiry through a robust pipeline and strategic acquisitions like Allergan. The company's strategy hinges on sustained leadership in immunology, accelerated growth in oncology and neuroscience, and financial discipline to fuel high R&D investment and shareholder returns.

View full company profile

Therapeutic Areas

ImmunologyOncologyNeuroscienceEye CareVirology

Other Prostate Cancer Drugs

DrugCompanyPhase
APVO442Aptevo TherapeuticsPreclinical
APVO452Aptevo TherapeuticsDiscovery
BIO 300Humanetics Corp.Not Specified
OpaganibRedHill BiopharmaPhase 2
Small-Molecule TherapeuticAIkido LabsPre-clinical
LeronlimabCytoDynPreclinical
ENV105Kairos PharmaPhase 2
AI for Prostate CancerInvenio ImagingResearch
Mitomic™ Test for Prostate CancerMDNA Life SciencesDevelopment/Validation
Immunomodulator PlatformOmniCyteResearch
Prostate cancer 'super test'EDX MedicalDevelopment
PSMA-DexDexTech MedicalPre-clinical